Dr.S.K.Kabra and G.C.Khilnani
Management
protocol for bird flu cases
When to
suspect:
Patents presenting with Fever (body temperature of 38o
Celsius or high) with one of the following symptoms:
Muscle ache, cough, abnormal breathing (unusual
breathing difficulty) or suspected pneumonia by the physician, or influenza
in addition to
History of direct contact with infected /
dead birds in past 7 days or
Occurrence of unusual death of birds in the
community within the past 14 days; or
Contact with a pneumonia patient or another
patient suspected of avian influenza
Case definition of
probable case: symptoms of suspected
case and
Preliminary test shows infection of influenza group
A, but cannot yet be confirmed whether it is from human or birds or
Respiratory failure or
Death
Case definition
of Confirmed cases: A suspected or probable case with at least one of the following:
• Positive viral culture for
influenza A/H5
• Positive RT PCR for
influenza A/H5
• Positive IFA for influenza
A/H5
• A 4 fold
rise in influenza A/H5 specific antibody titers.
Management guideline for all
suspected cases of avian flu:
Obtain NP swabs from all the patients (see annexure
1)
Assess severity of illness: Look for presence of
following:
Respiratory distress as indicated by: increased
respiratory rates, chest indrawing, dehydration,
hypotension, altered sensorium or oxygen saturation
of less than 93% in room air. If any of these are present patient should be
admitted to ward in designated area and manage on following principles
1.
Isolate cases
- Monitor vital signs every 1-2 hours
- Maintain
air way breathing and circulation (ABC)
- Maintain
hydration, electrolyte balance, and nutrition
- Provide
oxygen and assisted ventilation when indicated
- Manage
fever with paracetamol
- Give antiviral Oseltamivir
(For doses see annexure 2)
- Broad
spectrum antibiotics for treatment of secondary pulmonary infection
- Avoid
giving nebulized medications: chances of spread
Management of non severe cases
If patient is stable: (absence of above clinical
features): take NP aspirate from all the patients and isolate them in the
designated area identified for them and Start on Oseltamivir
Obtain lab results
and see clinical course. If lab tests negative: discontinue Oseltamivir
and provide supportive care, shift them to regular wards if hospitalization
indicated otherwise send them home
If lab test is positive: Transfer to designated in
patient area and continue supportive care and oseltamivir
Discharge policy
Adult patients:
Infection control precautions for 7 days after resolution of fever
Children:
Infection control measures for 21 days after onset of illness.
If discharged
earlier: child should not attend school and parents should be educated to
observe infection control measures at home.
Precautions for health care workers handling cases
of avian flu
Wear personal protective equipments
A.
Protective
clothings:
1.
Overall plus an impermeable apron or surgical gown with long cuffed
sleeves plus impermeable apron
2. Heavy duty rubber work gloves
that may be disinfected
3. Standard well fitted surgical masks should be used if N 95 respiratory masks are not
available.
4.
Goggles
5. Rubber or polyurethane
boots or protective foot cover
B .Chemoprophylaxis:
For close
contacts: Oseltamivir 75 mg daily for 7 days
Persons at risk: Oseltamivir 75 mg daily for the entire epidemic
C.
Monitoring of close contacts and health care workers exposed: observe for fever of
>38 Celsius, watery diarrhoea, pain abdomen,
headache, cough, rhinorrhoea, sore throat, shortness
of breath and CNS manifestations. Check for them daily till 14 days of last
exposure
Annexure 1
Collection
and transport of samples
Samples from upper
respiratory tract include
- Nsopharyngeal aspirate
- Nasal wash
- Throat swab
From lower respiratory tract samples include :
- Transtracheal aspirate
- Bronchoalveolar
lavage
- Lung biopsy
- Post-mortem lung or tracheal tissue
Specimens for the laboratory diagnosis of avian influenza A should be
collected in the following order of priority:
·
nasopharyngeal aspirate/swab
·
acute serum
·
convalescent serum.
The
sample collection should be done with all the necessary biosafety
precautions including use of gowns, gloves and masks
The
samples should be kept on ice and transported to virology laboratory as soon as
possible
Annexure II
Antiviral drugs
and their doses
Oseltamivir: is the only drug effective against H5N1 virus Doses
are:
•
Adults: 75 mg
twice a day for adults,
•
Children weighing
< 15 Kg:
30 mg twice a day
15-23
Kgs: 45 mg twice a day
23-40 kgs: 60
mg twice a day
> 40 kg: 75 mg twice a day
Adverse effects of oseltamivir
Nausea and vomiting: transient and occur in the
beginning and are self limiting
Abdominal pain, epistaxis,
conjuctivitis
Should be used in pregnancy with caution
Contraindications:
Hypersensitivity
to drug
Algorithm for management of Avian flu patients
Suspect case of Avian flu
(Patents presenting with Fever (body
temperature of 38o Celsius or high) with one of the following
symptoms: Muscle
ache, cough, abnormal breathing (unusual breathing difficulty) or suspected
pneumonia by the physician, or influenza in addition to History of
direct contact with infected / dead birds in past 7 days or Occurrence of unusual death of birds
in the community within the past 14 days; or Contact with a pneumonia
patient or another patient suspected of avian influenza)
Obtain NP aspirates and send to lab
Asses severity of illness
(Look for presence of
following Respiratory distress as indicated by: increased respiratory rates,
chest indrawing, dehydration, hypotension, altered sensorium or oxygen saturation of less than 93% in room
air)
Any one of the above present None of the above present
Admit in designated area and treat as
follows
Isolate cases
Monitor
vital signs every 1-2 hours
Maintain
air way breathing and circulation (ABC)
Maintain
hydration, electrolyte balance, and nutrition
Provide
oxygen and assisted ventilation when indicated
Manage
fever with paracetamol
Give
antiviral Oseltamivir (For doses see annexure 2)
Broad
spectrum antibiotics for treatment of secondary pulmonary infection
Avoid
giving nebulized medications: chances of spread
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Keep the patient in designated out patient area, start oseltamivir and collect lab report reportresults
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transfer to general ward and manage according to
|
|
|
|
Send home with supportive care
|
|